An outline of the MD simulations performed on the GLP-1R bound to Ex4-L-Ala ( a ), Ex4 ( b ) and Ex4-D-Ala ( c )
Although typically well-tolerated, possible side effects may include nausea, vomiting, diarrhea, constipation, fatigue, and injection site reactions
On one hand, the cardiovascular protection afforded by SGLT2is seems to result from their beneficial hemodynamic effects, including improvement in ventricular preload (secondary to natriuresis and osmotic diuresis) and afterload (through blood pressure reduction), but also from improvement of cardiac metabolism (through the switch from utilization of glucose to ketones), inhibition of the myocardial Na + /H + exchanger, reduction of cardiac fibrosis and necrosis, reduction of proinflammatory adipokines derived from epicardial and perivascular fat, and stimulation of erythropoiesis (which can facilitate the release of oxygen to ischemic tissues) [1, 4, 14,15,16]
Conversely, treatment of rats with the GIPR antagonist, rat GIP (330)NH2, does not modify food intake but significantly increases plasma TG and LPL compared with controls (Szalowska et al., 2011)
Protein is essential for muscle repair and growth, making it a key part of maintaining muscle while taking GLP-1 medications, notes Dr
